We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$79.7B
AUM Growth
+$3.42B
(+4.5%)
Cap. Flow
-$854M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
14.29%
Holding
1,817
New
122
Increased
851
Reduced
711
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$281M |
| 2 |
Comcast
CMCSA
|
+$235M |
| 3 |
Apple
AAPL
|
+$172M |
| 4 |
MetLife
MET
|
+$151M |
| 5 |
Mid-America Apartment Communities
MAA
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$399M |
| 2 |
UBS Group
UBS
|
+$393M |
| 3 |
Televisa
TV
|
+$305M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$278M |
| 5 |
New Oriental
EDU
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.42% |
| 2 | Financials | 13.04% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 11.9% |
| 5 | Technology | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYNO
551
DELISTED
Cynosure, Inc. Class A
CYNO
| $20.9M | 0.03% |
410,996
+153,183
| +59% | +$7.95M |
|
|
AMRN
552
Amarin Corp
AMRN
$284M
| $20.9M | 0.03% |
326,874
+60,925
| +23% | +$3.41M |
|
553
Cooper Companies
COO
$13.7B
| $20.8M | 0.03% |
464,372
+29,588
| +7% | +$1.35M |
|
|
FPRX
554
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $20.7M | 0.03% |
393,850
+2,210
| +0.6% | +$106K |
|
555
Avnet
AVT
$7.33B
| $20.6M | 0.03% |
502,166
+7,600
| +2% | +$310K |
|
556
Air Products & Chemicals
APD
$66.3B
| $20.6M | 0.03% |
148,220
-171,751
| -54% | -$23.8M |
|
557
Universal Health Services
UHS
$9.43B
| $20.6M | 0.03% |
167,183
-267,732
| -62% | -$33.9M |
|
|
TSE
558
DELISTED
Trinseo
TSE
| $20.6M | 0.03% |
+364,113
| New | +$19.3M |
|
559
Ball Corp
BALL
$17B
| $20.4M | 0.03% |
497,782
+228,674
| +85% | +$8.74M |
|
560
Acco Brands
ACCO
$369M
| $20.4M | 0.03% |
2,111,907
+49,915
| +2% | +$513K |
|
561
E.W. Scripps
SSP
$274M
| $20.3M | 0.03% |
1,273,886
-70,229
| -5% | -$1.17M |
|
|
IPHI
562
DELISTED
INPHI CORPORATION
IPHI
| $20.2M | 0.03% |
+464,350
| New | +$17.9M |
|
|
UFS
563
DELISTED
DOMTAR CORPORATION (New)
UFS
| $20.2M | 0.03% |
542,823
-42,134
| -7% | -$1.55M |
|
|
WNRL
564
DELISTED
Western Refining Logistics, LP
WNRL
| $20M | 0.03% |
863,500
+855,000
| +10,059% | +$20.3M |
|
|
ESL
565
DELISTED
Esterline Technologies
ESL
| $20M | 0.03% |
262,685
+86,105
| +49% | +$6.04M |
|
566
Huntington Bancshares
HBAN
$35.1B
| $19.9M | 0.03% |
2,016,931
+900
| +0% | +$8.57K |
|
|
NXTM
567
DELISTED
NxStage Medical Inc.
NXTM
| $19.9M | 0.02% |
795,221
+24,272
| +3% | +$566K |
|
568
Angi Inc
ANGI
$224M
| $19.8M | 0.02% |
200,204
+204
| +0.1% | +$17.9K |
|
|
PARA
569
DELISTED
Paramount Global Class B
PARA
| $19.8M | 0.02% |
361,627
-132,467
| -27% | -$7.03M |
|
570
HCA Healthcare
HCA
$84.8B
| $19.8M | 0.02% |
261,575
-80,127
| -23% | -$6.14M |
|
|
PLKI
571
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
| $19.7M | 0.02% |
370,206
+9,555
| +3% | +$533K |
|
|
DFT
572
DELISTED
DuPont Fabros Technology Inc.
DFT
| $19.6M | 0.02% |
475,603
+10,974
| +2% | +$495K |
|
|
MZOR
573
DELISTED
Mazor Robotics Ltd.
MZOR
| $19.6M | 0.02% |
+757,090
| New | +$16.8M |
|
|
JNPR
574
DELISTED
Juniper Networks
JNPR
| $19.6M | 0.02% |
812,701
+13,142
| +2% | +$304K |
|
|
NRF
575
DELISTED
NorthStar Realty Finance Corp.
NRF
| $19.5M | 0.02% |
1,477,825
-75,000
| -5% | -$969K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q3 2016 Portfolio in Review
As of Q3 2016, OppenheimerFunds held 1,817 positions worth $79.7B, up 4.5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q3 2016 filing shows 122 new, 851 increased, 711 reduced and 96 closed positions. Its largest new stake was Fomento Económico Mexicano: 1,462,419 shares worth $135M. The largest sale was Bristol-Myers Squibb, an estimated $399M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q3 2016 buy was Fomento Económico Mexicano: 1,462,419 shares worth $135M.
- OppenheimerFunds added most to Johnson Controls International in Q3 2016, an estimated $281M increase.
- OppenheimerFunds's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $399M.
- OppenheimerFunds fully exited UBS Group in Q3 2016, selling an estimated $393M.
- OppenheimerFunds's ten largest holdings make up 14% of its $79.7B portfolio in Q3 2016.
- OppenheimerFunds opened 122 new positions and closed 96 in Q3 2016.
- OppenheimerFunds's portfolio value rose 4.5% quarter-over-quarter to $79.7B.
Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.